Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint

Comment

Peter Grimm et al. BJU Int. 2012 Oct.

. 2012 Oct;110(8):E330-1.

doi: 10.1111/j.1464-410X.2012.11571_2.x.

No abstract available

Comment on

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. Grimm P, et al. BJU Int. 2012 Feb;109 Suppl 1:22-9. doi: 10.1111/j.1464-410X.2011.10827.x. BJU Int. 2012. PMID: 22239226 Review.
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.
Sooriakumaran P, Spahn M, Wiklund P. Sooriakumaran P, et al. BJU Int. 2012 Aug;110(4):477-8. doi: 10.1111/j.1464-410X.2012.11201.x. Epub 2012 May 8. BJU Int. 2012. PMID: 22568691 No abstract available.